Los puntos clave no están disponibles para este artículo en este momento.
Hydroxyurea and transfusion therapy are strongly recommended for many individuals with SCD. Many other recommendations are based on quality of evidence that is less than high due to the paucity of clinical trials regarding screening, management, and monitoring for individuals with SCD.
Yawn et al. (Tue,) studied this question.